Cancilico
The company develops AI-driven diagnostic solutions for haematology to automate and improve the accuracy of blood and bone marrow analysis.
Cancilico has raised €2.5M across 1 funding round from 4 investors, most recently a Seed round in Jan 2026. Based in Dresden, Germany; active in Healthtech. Data as of 28 Oct 2026.
Dresden, Germanycancilico.com ↗
Total raised
€2.5M
€2,500,000
Funding rounds
1
Investors
4
distinct backers
Active since
2026-01
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDCancilico — funding by year — interactive chart.
Data table
| Cancilico — funding by year | |
|---|---|
| 2026 | €2.5M |
Signals
High confidenceRaise-next likelihood53
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-20 | Seed | €2.5M | GEDAD GmbH,High-Tech Gründerfonds (HTGF),ROI Verwaltungsgesellschaft,Technologiegründerfonds Sachsen (TGFS) | View deal → |
Investors
4Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData